GH Research (GHRS) Operating Leases (2023 - 2025)

GH Research (GHRS) recorded quarterly Operating Leases of $365000.0 in Q4 2025, little changed quarter-over-quarter from $365000.0 in Q3 2025, and down 1.08% on a YoY basis from $369000.0 in Q4 2024.

GH Research (GHRS) Operating Leases (2023 - 2025) Analysis & Trends

GH Research's Operating Leases history runs 3 years deep, the most recent figure standing at $365000.0 for Q4 2025.

  • In Q4 2025, Operating Leases fell 1.08% year-over-year to $365000.0; the TTM figure through Dec 2025 stood at $365000.0 (down 1.08% YoY), while the FY2025 annual figure was $365000.0, down 1.08% from the prior year.
  • Operating Leases was $365000.0 for Q4 2025 at GH Research, roughly flat from $365000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.0 million in Q4 2023 to a low of $336000.0 in Q1 2025.
  • Historically, Operating Leases has averaged $541583.3 across 3 years, with a median of $477500.0 in 2024.
  • The sharpest annual moves came in 2024 and 2025: Operating Leases slumped 63.1% in 2024, then slipped 1.08% in 2025.
  • A 3-year view of Operating Leases shows it stood at $1.0 million in 2023, then plunged by 63.1% to $369000.0 in 2024, then dropped by 1.08% to $365000.0 in 2025.
  • The last three Operating Leases figures came in at $365000.0 (Q4 2025), $365000.0 (Q3 2025), and $364000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 GH Research 9.73 Bn 9.63 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 365,000.00
Sep 30, 2025 365,000.00
Jun 30, 2025 364,000.00
Mar 31, 2025 336,000.00
Dec 31, 2024 369,000.00
Sep 30, 2024 458,000.00
Jun 30, 2024 497,000.00
Mar 31, 2024 561,000.00
Dec 31, 2023 1.00 Mn
Sep 30, 2023 661,000.00
Jun 30, 2023 732,000.00
Mar 31, 2023 791,000.00